HomeBCTX • NASDAQ
add
Briacell Therapeutics Corp
Previous close
$4.22
Day range
$4.17 - $4.37
Year range
$3.60 - $98.10
Market cap
43.14M CAD
Avg Volume
219.59K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Financials
Income Statement
Revenue
Net income
| (USD) | Jan 2026info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.53M | 5.05% |
Net income | -7.22M | -14.79% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -7.50M | -5.07% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jan 2026info | Y/Y change |
|---|---|---|
Cash and short-term investments | 29.90M | 496.44% |
Total assets | 33.59M | 258.78% |
Total liabilities | 3.38M | -44.91% |
Total equity | 30.21M | — |
Shares outstanding | 7.25M | — |
Price to book | 0.99 | — |
Return on assets | -80.69% | — |
Return on capital | -95.18% | — |
Cash Flow
Net change in cash
| (USD) | Jan 2026info | Y/Y change |
|---|---|---|
Net income | -7.22M | -14.79% |
Cash from operations | -7.97M | -34.58% |
Cash from investing | 7.28M | 9,809.96% |
Cash from financing | 27.87M | 434.34% |
Net change in cash | 27.19M | 3,592.07% |
Free cash flow | -5.63M | -54.28% |
About
Founded
2006
Headquarters
Website
Employees
22
